Literature DB >> 28518409

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.

J M Findlay, K M Bradley, L M Wang, J M Franklin, E J Teoh, F V Gleeson, N D Maynard, R S Gillies, M R Middleton.   

Abstract

Entities:  

Year:  2017        PMID： 28518409     DOI： 10.1002/bjs.10611

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  3 in total

1.  PET-guided treatment algorithms in oesophageal cancer: the promise of the near future!

Authors:  Lioe-Fee de Geus-Oei; Marije Slingerland
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

2.  Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence.

Authors:  John M Findlay; Edward Dickson; Cristina Fiorani; Kevin M Bradley; Somnath Mukherjee; Richard S Gillies; Nicholas D Maynard; Mark R Middleton
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

3.  Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery.

Authors:  John M Findlay; Stefan Antonowicz; Ashvina Segaran; Jihene El Kafsi; Alexa Zhang; Kevin M Bradley; Richard S Gillies; Nicholas D Maynard; Mark R Middleton
Journal:  Eur Radiol       Date:  2019-01-14       Impact factor: 5.315
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.